financetom
Business
financetom
/
Business
/
Enphase Energy Stock Slides On Q3 Earnings Miss: US Revenue Jumps, European Revenue Falls On 'Further Softening' Demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enphase Energy Stock Slides On Q3 Earnings Miss: US Revenue Jumps, European Revenue Falls On 'Further Softening' Demand
Oct 22, 2024 2:21 PM

Enphase Energy Inc ( ENPH ) reported third-quarter financial results on Tuesday that came up short of analyst expectations. Here are the main highlights from the quarter.

Q3 Earnings: Enphase Energy ( ENPH ) reported third-quarter revenue of $380.9 million, missing the consensus estimate of $391.979 million. The solar company reported adjusted earnings of 65 cents per share, missing analyst estimates of 77 cents per share, according to Benzinga Pro.

U.S. revenue increased approximately 43% on a quarter-over-quarter basis due to higher shipments to distributors. Meanwhile, revenues in Europe fell approximately 15% quarter-over-quarter, driven by a “further softening” in European demand.

Enphase shipped 172.9 megawatt hours of IQ batteries in the quarter and shipped approximately 1,176,000 microinverters from its contract manufacturing facilities in the U.S. The company also highlighted the launch of its AI-based software for energy optimization in the quarter.

“We began shipping IQ8HC microinverters with higher domestic content, produced at our contract manufacturing facilities in the U.S. We expect to begin shipping our commercial microinverters, and batteries with higher domestic content, produced at our U.S. contract manufacturing facilities in the fourth quarter of 2024,” the company said.

Enphase said it generated $170.1 million in cash flow from operations and $161.3 million in free cash flow during the quarter. The company ended the quarter with $1.77 billion in cash, cash equivalents and marketable securities.

Related Link: This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Outlook: Enphase expects fourth-quarter revenue to be in the range of $360 million to $400 million. The company anticipates third quarter gross margin of 47% to 50%, or 49% to 52% on an adjusted basis.

Management will hold a conference call to further discuss these results with analysts and investors at 4:30 p.m. ET.

ENPH Price Action: Enphase shares were down 7.31% in after-hours, trading at $85.20 at the time of publication Tuesday, according to Benzinga Pro.

Read Next:

Boeing Stock Braces For Bumpy Q3 Landing

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amesite Plans Public Offering; Shares Fall After Hours
Amesite Plans Public Offering; Shares Fall After Hours
Jan 6, 2025
05:32 PM EST, 01/06/2025 (MT Newswires) -- Amesite ( AMST ) said late Monday it plans a best efforts underwritten public offering of an undisclosed amount of its common shares or pre-funded warrants. The company said it intends to use the net proceeds for general corporate purposes, among other things. Amesite ( AMST ) shares were down nearly 21% in...
AerCap Units Price $1.5 Billion Debt Offering
AerCap Units Price $1.5 Billion Debt Offering
Jan 6, 2025
05:39 PM EST, 01/06/2025 (MT Newswires) -- AerCap Holdings ( AER ) said late Monday that two units priced a $1.5 billion offering of two series of senior notes. The offering consists of $750 million of 4.875% notes due 2028 and $750 million of 5.375% notes due 2031. The units plan to use the net proceeds for general corporate purposes,...
Kura Oncology Promotes Mollie Leoni to Chief Medical Officer
Kura Oncology Promotes Mollie Leoni to Chief Medical Officer
Jan 6, 2025
05:35 PM EST, 01/06/2025 (MT Newswires) -- Kura Oncology ( KURA ) said Monday it has promoted Mollie Leoni to chief medical officer. Leoni succeeds Stephen Dale, who has resigned as chief medical officer to prioritize recovery from personal health issues, effective Jan. 2. Leoni was previously the executive vice president of clinical development and led the company's ziftomenib program...
Novonix Plans to Sign Land Agreement for Synthetic Graphite Plant
Novonix Plans to Sign Land Agreement for Synthetic Graphite Plant
Jan 6, 2025
05:39 PM EST, 01/06/2025 (MT Newswires) -- Novonix ( NVX ) said late Monday that it plans to sign a purchase and sale agreement for the land to be used for its second mass production plant with the City of Chattanooga, Tennessee and Hamilton County, Tennessee. The execution of the agreement is subject to approvals of the City of Chattanooga...
Copyright 2023-2026 - www.financetom.com All Rights Reserved